Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0JTGGZ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anticancer antibody-drug conjugate (Vaccinex/Catalent Pharma Solutions)
|
|||||
| Synonyms |
Anticancer ADC Vaccinex/Catalent Pharma Solutions
Click to Show/Hide
|
|||||
| Organization |
Vaccinex, Inc.; Catalent Pharma Solutions, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Solid tumors [ICD11:2A00-2A0Z|2B50-2F9Z]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.